NCT05690698View on ClinicalTrials.gov

Quetiapine Versus Haloperidol in the Management of Hyperactive Delirium

PHASE3CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

April 9, 2023

Primary Completion Date

July 15, 2023

Study Completion Date

July 15, 2023

Conditions

Hyperactive Delirium

Interventions

DRUG

Quatiapine

Atypical antipsychotic

DRUG

Haloperidol

Antipsychotic

Trial Locations (1)

Unknown

Faculty of Medicine, Alexandria University Hospitals, Alexandria

All Listed Sponsors

lead

Alexandria University

OTHER